about
Risk of cancer among firefighters in California, 1988-2007Epidemiology of esophageal cancerEsophageal Cancer: Insights From Mouse ModelsBOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia.Polymorphisms in Genes of Relevance for Oestrogen and Oxytocin Pathways and Risk of Barrett's Oesophagus and Oesophageal Adenocarcinoma: A Pooled Analysis from the BEACON Consortium.Marital status and survival after oesophageal cancer surgery: a population-based nationwide cohort study in Sweden.Physical activity is associated with reduced risk of esophageal cancer, particularly esophageal adenocarcinoma: a systematic review and meta-analysis.Intensity modulated radiotherapy (IMRT) with concurrent chemotherapy as definitive treatment of locally advanced esophageal cancer.Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysisHospital and surgeon volume in relation to long-term survival after oesophagectomy: systematic review and meta-analysis.Early complications following oesophagectomy for cancer in relation to long-term healthcare utilisation: a prospective population-based cohort studyAssociation between education level and prognosis after esophageal cancer surgery: a Swedish population-based cohort study.Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences.Microbiome and potential targets for chemoprevention of esophageal adenocarcinoma.Incidence of esophageal cancer in Sri Lanka: Analysis of cancer registry data and comparison with other South Asian populations.Cost-Effectiveness Analysis on Endoscopic Surveillance Among Western Patients With Barrett's Esophagus for Esophageal Adenocarcinoma Screening.The effect of paclitaxel-eluting covered metal stents versus covered metal stents in a rabbit esophageal squamous carcinoma model.Long-term trends and survival analysis of esophageal and gastric cancer in Yangzhong, 1991-2013.Polymorphisms in genes in the androgen pathway and risk of Barrett's esophagus and esophageal adenocarcinoma.Effectiveness of focal vs. balloon radiofrequency ablation devices in the treatment of Barrett's esophagusThe therapeutic response of CDDO-Me in the esophageal squamous cell carcinoma (ESCC) cells is mediated by CaMKIIα.Fibroblast growth factor receptor 2 expression, but not its genetic amplification, is associated with tumor growth and worse survival in esophagogastric junction adenocarcinoma.DNA polymerase iota (Pol ι) promotes invasion and metastasis of esophageal squamous cell carcinoma.A global assessment of the male predominance in esophageal adenocarcinoma.Gastrointestinal malignancy and the microbiome.Prognosis-related microRNAs in esophageal cancer.Hormone replacement therapy and oral contraceptives and risk of oesophageal adenocarcinoma: a systematic review and meta-analysis.Docetaxel and its potential in the treatment of refractory esophagogastric adenocarcinoma.Incidence of brain metastasis from esophageal cancer.Toward improved survivorship: supportive care needs of esophageal cancer patients, a literature review.Cachexia in patients with oesophageal cancer.Racial and Ethnic Disparities in the Incidence of Esophageal Cancer in the United States, 1992-2013.Enhanced expression of early mitotic inhibitor-1 predicts a poor prognosis in esophageal squamous cell carcinoma patients.The Genetics of Barrett's Esophagus: A Familial and Population-Based Perspective.Preliminary evaluation for Bit1 as a potential biomarker for squamous cell carcinoma and adenocarcinoma of esophagus.Total minimally invasive esophagectomy for esophageal cancer: approaches and outcomes.A model for predicting individuals' absolute risk of esophageal adenocarcinoma: Moving toward tailored screening and prevention.Menopausal hormone therapy and the risk of esophageal and gastric cancer.The genetics of gastroesophageal adenocarcinoma and the use of circulating cell free DNA for disease detection and monitoring.Relief of dysphagia during neoadjuvant treatment for cancer of the esophagus or gastroesophageal junction.
P2860
Q23920018-B1FE360D-B3F1-4F82-87A7-43FD6D8DFAA8Q24625927-624E0626-F7FC-4392-B10E-AEA4DBEC965CQ26783904-5F286B6E-BF1D-49BD-8CD1-6253D236B42FQ27332349-553C212A-F368-486C-B073-117A28BA2DB4Q33361584-C5AE9DCC-5CAC-4947-9303-FCF8A95A482CQ33744745-BC664DC0-FC03-40CA-8F03-3FEBD89B51BAQ33756930-0758B908-A478-4E6E-A752-2E3104990848Q34143984-B840C5B6-82AD-4623-9223-92942D10BCC5Q34352867-96F2AFED-FC48-4208-B5A4-E8B9C834CCB3Q35051950-4C8C9D0B-B774-45A7-9B4F-873BE63C3819Q35175175-7BBEAEAA-3574-405F-9316-BE2DCD1F8CE1Q35219905-EED4FE66-5299-4493-BAC7-CD578F70C26BQ35763725-ACE5CCA6-9B35-4E4D-8CD3-C9E28DE503FDQ35954977-D1E75D66-5851-481F-8ACA-A7616FC0476FQ35974653-60760A91-522E-456B-B464-C8B20F7A221CQ36195716-06E71DB9-13AF-45CB-AD0F-6AEF3F362896Q36295562-75991B0E-F00B-4BF1-91E9-FC038DDA97F2Q36306282-73881F44-4CF8-4039-AD99-C04D9100B47BQ36470039-DC374C93-2781-480A-A741-12CC8137EE6AQ36719793-4D7C2970-1483-417C-B9C8-B3196B477947Q36879554-B55B330B-6236-4BCD-99FA-16EF18FDD3D2Q37190164-6ED513BA-F2F0-441C-A904-BB2DCAA418A1Q37362656-D0A984DB-75ED-4015-8F25-6E5F35AA4D61Q37437702-1B06A218-BAB2-4E52-B796-7180F48AC165Q37716976-955B0C6D-A471-4529-ADAE-BD4A4C918D67Q38186129-C33178AE-DDDB-46E0-B612-4632CA5D002BQ38200006-1A7E3562-7A63-4F79-84A9-07CB485FE99AQ38542060-F926671C-B6EB-4E55-A398-B55AB525C7DEQ38599600-C6AB2087-937F-41DD-826B-213EAE385DCAQ38604112-B763A052-C7EF-4F03-BB1B-2B02AD7A5F28Q38634739-FD51A45C-0DBB-45FB-98EF-0EAD501D15AEQ38713550-14D5D8E0-19F9-459A-9B35-0BBB54875023Q38761750-4D434EF3-355A-4341-B844-F2B88A316B3BQ38771931-57000895-0CBF-42FA-A2C1-CD672F80ACD8Q38794745-A79A3C3E-36D1-4A2A-BDB1-091FF1A99CA8Q38892869-8DBCC57A-06EF-4929-9FF5-420200114377Q38921914-1F3909FD-4A63-42C7-9E7B-EAAEF9B8FEFDQ39071963-9C3A5343-D16D-437F-918D-2B0E0592E328Q39183864-213EC913-E5EB-41EC-98EC-89C48F1CDAB3Q39192013-F7FFA976-F6B7-4424-88F0-77797EFC1A73
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Recent developments in esophageal adenocarcinoma
@ast
Recent developments in esophageal adenocarcinoma
@en
Recent developments in esophageal adenocarcinoma
@nl
type
label
Recent developments in esophageal adenocarcinoma
@ast
Recent developments in esophageal adenocarcinoma
@en
Recent developments in esophageal adenocarcinoma
@nl
prefLabel
Recent developments in esophageal adenocarcinoma
@ast
Recent developments in esophageal adenocarcinoma
@en
Recent developments in esophageal adenocarcinoma
@nl
P2860
P3181
P356
P1433
P1476
Recent developments in esophageal adenocarcinoma
@en
P2860
P304
P3181
P356
10.3322/CAAC.21185
P407
P577
2013-01-01T00:00:00Z